Work

Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)

Year: 2021

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-021-01090-w

Authors: Nguyen H Tran, Nathan R Foster, Amit Mahipal, Thomas Byrne, Joleen Hubbard, Alvin Silva, Kabir Mody, Steven Alberts, Mitesh J. Borad

Institutions: Mayo Clinic, Mayo Clinic Hospital, Mayo Clinic in Arizona, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), Mayo Clinic Comprehensive Cancer Center (Arizona)

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G3100437649, G4185274752, NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care, Oncolytic Virotherapy in Hepatocellular Cancer, G7114658202, G8225661566, Alliance for Clinical Trials in Oncology Operations Center, G9000280145, Mayo Clinic Comprehensive Cancer Center Support Grant, Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic

OpenAlex ID: W3135596333

FWCI: 0.701

Cites: 50

Cited by: 9

Related to: 10